Industry Discovery & Development Partnership (IDDP) Program
Breakthrough T1D’s IDDP Program funds for-profit research advancing new therapies and technologies for type 1 diabetes in key priority areas, fostering industry collaboration and scientific innovation.
Funder: Breakthrough T1D
Due Dates: Rolling (LOIs accepted year-round; no fixed deadlines)
Funding Amounts: Typically up to $750,000 total over 2 years; larger requests considered with strong justification; no indirect costs allowed.
Summary: Provides funding to for-profit organizations for research projects closely aligned with Breakthrough T1D’s priority areas to accelerate new treatments and therapies for type 1 diabetes.
Key Information: Requires company matching funds; LOIs are required and can be submitted at any time.
Description
The Industry Discovery & Development Partnership (IDDP) Program from Breakthrough T1D supports for-profit organizations conducting research that advances the foundation’s strategic priorities in type 1 diabetes (T1D). The program is designed to leverage the commercial expertise of industry partners, accelerating the development of new treatments and therapies with high potential for clinical and commercial impact. Breakthrough T1D collaborates with funded companies, offering scientific guidance and access to its global research and advocacy network.
Projects must align closely with Breakthrough T1D’s research strategy, which includes areas such as disease-modifying therapies, beta cell replacement, immune tolerance, prevention, and the management of T1D complications. The program is open to a wide range of research types, including preclinical and clinical studies, technology development, and translational research.
